Go Back
Phosphorylations for 'MDM2'
Source | Sequence | Kinase Gene | Detection Level | Kinase Description | Reference | Experiment type |
---|---|---|---|---|---|---|
S 17 (9,7,4) | ||||||
TDGAVTTSQIPASEQ | ||||||
S 23 (5,6,1,3,2,8) | ||||||
TDGAVTTSQIPASEQ | ||||||
S 70 (9) | ||||||
GDWLDQDSVSDQFSV | ||||||
S 72 (9) | ||||||
WLDQDSVSDQFSVEF | ||||||
S 76 (9) | ||||||
DSVSDQFSVEFEVES | ||||||
S 83 (9) | ||||||
SVEFEVESLDSEDYS | ||||||
S 86 (9) | ||||||
FEVESLDSEDYSLSE | ||||||
S 90 (9) | ||||||
SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
S 92 (9) | ||||||
DSEDYSLSEEGQELS | ||||||
T 107 (6) | ||||||
KEFEREETQDKEESV | ||||||
S 113 (6) | ||||||
ETQDKEESVESSLPL | ||||||
S 117 (6) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
S 137 (8) | ||||||
RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
S 139 (8) | ||||||
RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
S 157 (7) | ||||||
SHLVSRPSTSSRRRA | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
S 163 (1,2) | ||||||
SHLVSRPSTSSRRRA | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
S 166 (7) | ||||||
SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
SSRRRAISETEENSD | DAPK3 | death-associated protein kinase 3 | ||||
SSRRRAISETEENSD | PIM1 | pim-1 oncogene | ||||
SSRRRAISETEENSD | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
VSRPSTSSRRRAISE | ||||||
VSRPSTSSRRRAISE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
S 172 (1) | ||||||
SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
SSRRRAISETEENSD | DAPK3 | death-associated protein kinase 3 | ||||
SSRRRAISETEENSD | PIM1 | pim-1 oncogene | ||||
SSRRRAISETEENSD | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
SSRRRAISETEETQD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
S 183 (2) | ||||||
ETQDKEESVESSLPL | ||||||
S 186 (7) | ||||||
RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
S 187 (2) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
S 188 (7) | ||||||
RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
S 190 (9) | ||||||
DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
S 191 (8) | ||||||
GDWLDQDSVSDQFSV | ||||||
S 192 (1) | ||||||
RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
S 193 (8) | ||||||
WLDQDSVSDQFSVEF | ||||||
S 194 (1) | ||||||
RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
S 197 (8) | ||||||
DSVSDQFSVEFEVES | ||||||
Y 198 (9) | ||||||
QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 199 (9) | ||||||
SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
S 204 (8) | ||||||
SVEFEVESLDSEDYS | ||||||
S 207 (8) | ||||||
FEVESLDSEDYSLSE | ||||||
Y 209 (9) | ||||||
STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 211 (8) | ||||||
SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
S 213 (8) | ||||||
DSEDYSLSEEGQELS | ||||||
S 220 (8) | ||||||
SEEGQELSDEDDEVY | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
T 223 (9) | ||||||
KEFEREETQDKEESV | ||||||
Y 227 (8) | ||||||
SDEDDEVYQVTVYQA | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 229 (9) | ||||||
ETQDKEESVESSLPL | ||||||
S 233 (9) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
S 246 (1) | ||||||
GDWLDQDSVSDQFSV | ||||||
S 248 (1) | ||||||
WLDQDSVSDQFSVEF | ||||||
S 252 (1) | ||||||
DSVSDQFSVEFEVES | ||||||
S 259 (1) | ||||||
SVEFEVESLDSEDYS | ||||||
S 262 (1) | ||||||
FEVESLDSEDYSLSE | ||||||
S 266 (1) | ||||||
SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
S 268 (1) | ||||||
DSEDYSLSEEGQELS | ||||||
S 275 (1) | ||||||
SEEGQELSDEDDEVY | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
Y 282 (1) | ||||||
SDEDDEVYQVTVYQA | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 337 (8) | ||||||
DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
S 339 (7) | ||||||
DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
Y 345 (8) | ||||||
QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 346 (8) | ||||||
SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
Y 347 (7) | ||||||
QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 348 (7) | ||||||
SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
Y 356 (8) | ||||||
STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 358 (8) | ||||||
SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
Y 358 (7) | ||||||
STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 360 (7) | ||||||
SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
T 370 (8) | ||||||
KEFEREETQDKEESV | ||||||
T 372 (7) | ||||||
KEFEREETQDKEESV | ||||||
S 376 (8) | ||||||
ETQDKEESVESSLPL | ||||||
S 378 (7) | ||||||
ETQDKEESVESSLPL | ||||||
S 380 (8) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
S 382 (7) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
S 392 (1) | ||||||
DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
Y 400 (1) | ||||||
QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 401 (1) | ||||||
SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
Y 411 (1) | ||||||
STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
S 413 (1) | ||||||
SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
T 425 (1) | ||||||
KEFEREETQDKEESV | ||||||
S 431 (1) | ||||||
ETQDKEESVESSLPL | ||||||
S 435 (1) | ||||||
KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated |